Popular Articles

Unisense FertiliTech A/S Receives CE Mark Of Approval For EmbryoScope(TM) Embryo Monitoring System
Unisense FertiliTech A/S announces that the EmbryoScope(TM) Embryo Monitoring System and EmbryoSlide(TM) tray have received CE approval as class IIa medical devices for use in IVF. Unisense Fertilitech A/S also received the DS/EN ISO13485:2003 and AC:2007 quality system certificate for production, installation and servicing of IVF incubators and related accessories.

First Confirmed Case Of H1N1 (Swine) Flu In Coconino County
Coconino County Health Department (CCHD) officials announced today the first case of H1N1 (swine) flu in Coconino County. The Arizona Department of Health Services Lab confirmed that a 24 year-old male from the Navajo Nation has tested positive for the illness. The man went to the Tuba City Regional Health Care Corporation Emergency Department with flu-like symptoms and was tested. He is now recovering from the illness.
News of the day
Crohn's Disease: Case Western Reserve Researchers Identify Links Between Inflammatory Disease Genes
Researchers from Case Western Reserve University School of Medicine identified a novel link between ITCH, a gene known to regulate inflammation in the body and NOD2, a gene which causes the majority of genetic Crohn"s Disease diagnoses. ITCH, when malfunctioning, causes widespread inflammatory diseases, including inflammatory bowel disease, gastritis, uncontrolled skin inflammation, and pulmonary pneumonitis. Derek Abbott, M.D., Ph.D., and his team of researchers found that ITCH also influences NOD2-induced inflammation. These findings, published in the August 11th issue of Current Biology, suggest a common pathophysiology exists between multiple inflammatory diseases. The unexpected finding of the interaction between these genes offers the possibility of a new drug target, which would be effective in treating Crohn"s disease - a chronic disorder causing inflammation of the gastrointestinal tract.
Mental Health

Hospitals May Strike Deal To Save $200 Billion

Hospitals could sign on to an agreement with Senate health reform leader Max Baucus, D-Mont., and the White House to help save up to $200 billion as part of the overhaul plan, lobbyist and health industry s tell Roll Call. The possible deal would come on the heels of an agreement between the drug industry lobbying group, Pharmaceutical Research and Manufacturers of America and senior Democrats to save $80 billion over 10 years by expanding the Medicare drug program. The American Hospital Association, the Federation of American Hospitals and the Catholic Health Association are all said to be in talks about the potential bargain. It"s unclear what the hospitals would get, but Roll Call reports: "One area targeted by some lawmakers for savings would come from the Medicare and Medicaid disproportionate-share payment programs that reimburse hospitals for providing services to patients who are uninsured or whose treatments are not fully covered. Hospitals say the program would naturally see significant cost savings if all Americans have health coverage, but they caution that making the cuts before health reforms have been implemented could do more harm." Other sectors of the industry did not yet appear ready to pursue similar deals, but insurance and physician groups said they were engaged in conversations with members of Congress, and were prepared to make some sacrifices (Ackley, 6/24). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):